Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising results. However, the price of this innovative drug and its supply have become key concerns for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its expensive nature presents a significant challenge to many.